Literature DB >> 7834040

[Sulfite oxidase deficiency presenting as Leigh syndrome].

J Amiel1, V Gagey, D Rabier, C Dorche, J P Bonnefont, J L Dufier, J M Saudubray, J Rey, A Munnich.   

Abstract

BACKGROUND: An enzyme deficiency can be demonstrated in 15 to 20% of cases of Leigh syndrome. A case of isolated sulphite oxidase deficiency is reported in a girl presenting with Leigh syndrome. CASE REPORT: An 8 month-old girl was admitted suffering from hypotonia and slow increase of head circumference (-1 SD). Examination showed spastic quadriplegia, dyskinesia, axial hypotonia and difficulties in swallowing. The patient had a coarse face, broad nasal bridge, long philtrum and ectopia lentis. Brain CT scan showed bilateral hypodensity of lenticular nuclei and moderate cortical atrophy. Amino acid chromatography showed accumulation of S sulfocysteine and low levels of cysteine. The sulphite test was positive. Sulphite oxidase activity in fibroblasts and liver was undetectable contrasting with a normal activity of xanthine oxidase. Progressive brain damage led to death at 1 year of age. Prenatal diagnosis of sulphite oxidase deficiency was made in two further pregnancies.
CONCLUSIONS: The search for sulphite oxidase deficiency must be included in discussing the etiology of Leigh syndrome; the sulphite test is a simple method of screening such cases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834040

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Isolated sulfite oxidase deficiency: MR imaging features.

Authors:  Arthur B Dublin; John K Hald; Sandra L Wootton-Gorges
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement.

Authors:  G Touati; E Rusthoven; E Depondt; C Dorche; M Duran; B Heron; D Rabier; M Russo; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.